Generic Name and Formulations:
Guselkumab 100mg/mL; soln for SC inj; preservative-free.
Janssen Biotech, Inc.
Indications for TREMFYA:
Moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
≥18yrs: 100mg by SC inj at Weeks 0 and 4, then every 8 weeks thereafter.
<18yrs: not established.
Use under physician supervision. May increase risk of infections. Chronic or history of recurrent infection: consider the risks and benefits. If a serious infection develops or is not responding to standard therapy, monitor closely and discontinue until resolves. Evaluate for tuberculosis (TB) infection and treat latent TB prior to initiating. Monitor for signs/symptoms of active TB during and after therapy. Patients with active TB infection: do not initiate. History of latent or active TB (without confirmed adequate treatment); consider anti-TB therapy prior to initiation. Consider completion of all age appropriate immunizations according to current guidelines before starting therapy. Pregnancy. Nursing mothers.
Concomitant live vaccines: not recommended. Concomitant CYP450 substrates with narrow therapeutic index: monitor and adjust dose as needed.
Upper respiratory infections, headache, inj site reactions, arthralgia, diarrhea, gastroenteritis, tinea infections, herpes simplex infections.
Single-dose prefilled syringe—1
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Suicide Attempt Risk Among LGB Populations Higher Than Previously Estimated
- Residents Should Take Advantage of Paid Time Off
- Outpatient Engagement May Lower Suicide Attempts in Patients With Fibromyalgia
- Prevalence of Alzheimer Disease, Related Dementia Set to Double
- Forms of Childhood Adversity Related to First-Episode Psychosis Outcomes